ConductScience.org, home

Paper42579251

Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.

Yang J. Discov Nano, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies. Papers, record 42579251. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579251

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.
PubMed
Journal
Discov Nano
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang JJinghttps://orcid.org/0009-0008-7319-8878

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References272

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128960167PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma.Nanomedicine (Lond)2017https://conductscience.org/library/papers/28960167PubMed
238255922Aliskiren-Loaded Nanoparticles Downregulate (Pro)renin Receptor and ACE Gene Expression in the Heart of Spontaneously Hypertensive Rats: Effect on NADPH Oxidase.Int J Mol Sci2024https://conductscience.org/library/papers/38255922PubMed
339392505Synthesis and characterization of molecularly imprinted polymer nanoparticles against porcine circovirus type 2 viral-like particles.Anal Bioanal Chem2024https://conductscience.org/library/papers/39392505PubMed
437646313Synergetic EGCG and coenzyme Q10 DSPC liposome nanoparticles protect against myocardial infarction.Biomater Sci2023https://conductscience.org/library/papers/37646313PubMed
539403576Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39403576PubMed
640722790Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies.Biomedicines2025https://conductscience.org/library/papers/40722790PubMed
730660748Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers.Int J Pharm2019https://conductscience.org/library/papers/30660748PubMed
840893381Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction.Mater Today Bio2025https://conductscience.org/library/papers/40893381PubMed
938873669Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment.Heliyon2024https://conductscience.org/library/papers/38873669PubMed
1041771322Apolipoprotein M: Structural insights, functional roles, and therapeutic approaches in vascular disease.J Biol Chem2026https://conductscience.org/library/papers/41771322PubMed
1137646052An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.Adv Pharm Bull2023https://conductscience.org/library/papers/37646052PubMed
1239218342Nanomedicine: A great boon for cardiac regenerative medicine.Eur J Pharmacol2024https://conductscience.org/library/papers/39218342PubMed
1337500736Uptake and anti-inflammatory effects of liposomal astaxanthin on endothelial cells tracked by Raman and fluorescence imaging.Mikrochim Acta2023https://conductscience.org/library/papers/37500736PubMed
1436898531Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy.J Control Release2023https://conductscience.org/library/papers/36898531PubMed
1541674372Fusogenic Hybrid Gelled Nanovesicles Combining Mesenchymal Stromal Cell Cargo with Cholesterol-Modified Macrophage Membranes for Targeted Myocardial Infarction Therapy.ACS Nano2026https://conductscience.org/library/papers/41674372PubMed
1641458564Engineering Optimized Nanostructured Lipid Carriers for Astaxanthin: A Response Surface Methodology Approach.Int J Nanomedicine2025https://conductscience.org/library/papers/41458564PubMed
1741282621Potential of herbal formulas and bioactive metabolites in treating atherosclerosis: targeted modulation of macrophage polarization.Front Pharmacol2025https://conductscience.org/library/papers/41282621PubMed
1839831819Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity.Eur Heart J2025https://conductscience.org/library/papers/39831819PubMed
1935600953Natural Herbal Medicine as a Treatment Strategy for Myocardial Infarction through the Regulation of Angiogenesis.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35600953PubMed
2033782898Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.Drug Deliv Transl Res2022https://conductscience.org/library/papers/33782898PubMed

See all 272 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42579251

GET https://conductscience.org/api/papers/v1/42579251/references?page=2